Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
There are significant barriers to cervical cancer screening. Sample self-collection promises to improve access to testing and treatment.
In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, of BD, returns to discuss BD and MD Anderson’s HPV self-collection study.
Seegene demonstrated its new HPV diagnostic products and emphasized the importance of HPV screening at the AOGIN conference.
Read MoreResearchers developed a urine test using ELISA to detect HPV16 E7 oncoproteins, a noninvasive method for cervical cancer screening.
Read MoreA new study highlights support among healthcare providers for HPV self-collection, which could improve access to cervical cancer screening.
Read MoreResearchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read MoreBD received FDA approval for women to self-collect vaginal specimens for HPV testing, expanding access to cervical cancer screening.
Read Moreche received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read MoreAn at-home cervical cancer screening device received Breakthrough Device status to help increase testing access for people in need.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreThe research highlighted factors influencing cervical cancer screening and highlighted the need for interventions to increase screening.
Read MoreThe TTMV-HPV DNA blood test provides a non-invasive method for detecting HPV-driven cancers before there is clinical evidence of disease.
Read MoreThe ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read MoreNaveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read MoreBD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read MoreIn BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read MoreResearchers discovered that lymphatic fluid from surgical drains could inform precise treatments for patients with head and neck cancer.
Read More